Anti-tumour activity of bisphosphonates in preclinical models of breast cancer.

In particular, there may be significant differences in therapeutic response recorded between xenograft studies that use immunocompromised mice and studies using murine mammary carcinoma models in immunocompetent mice.

also in 13,097 other papers